Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studies

✍ Scribed by Alessandra Fabi; Giulio Metro; Gianluigi Ferretti; Diana Giannarelli; Serena Di Cosimo; Paola Papaldo; Marcella Mottolese; Paolo Carlini; Alessandra Felici; Michelangelo Russillo; Francesco Cognetti

• Book ID: 113507034
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 161 KB
• Volume: 17
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/j.breast.2008.03.006